Navigation Links
Treatment for Cigarette, Alcohol & Drug Use During Pregnancy Dramatically Improves Outcomes for Mom and Baby, Kaiser Permanente Study Shows
Date:6/26/2008

Largest study to date examined nearly 50,000 pregnant women

OAKLAND, Calif., June 26 /PRNewswire/ -- Pregnant women who receive treatment for substance abuse early in their pregnancy can achieve the same health outcomes as pregnant women with no substance abuse, according to a Kaiser Permanente study published online in the Journal of Perinatology.

The study, which is the largest to date, examined 49,985 women in Kaiser Permanente's prenatal care program and found that integrating substance abuse screening and treatment into routine prenatal care helped pregnant women achieve similar health outcomes as women who were not using cigarettes, alcohol or other drugs. This is also the largest study to examine multiple substances: cigarettes, alcohol, marijuana, methamphetamines, cocaine and heroin.

"This program can happen everywhere and should become the gold standard for women who are pregnant and using cigarettes, alcohol or other drugs," said study lead author Nancy C. Goler, M.D., an OB/GYN and Kaiser Permanente regional medical director of the Early Start Program for the organization's Northern California operations. "The study's big finding was that study participants treated in the Early Start program had outcomes similar to our control group, women who had no evidence of substance abuse."

The study compared 2,073 pregnant women who were screened, assessed and received ongoing intervention during pregnancy through the Early Start program at 21 Kaiser Permanente Northern California outpatient obstetric clinics from 1999 to 2003 to women in three other groups: 156 women who were screened but did not accept assessment or treatment; 1,203 women were screened, assessed and received brief intervention only; and a control group of 46,553 women who showed no evidence of substance abuse.

The study found the risk of stillborn, placental abruption (when the placental lining separates from the mother's uterus), pre-term delivery,
'/>"/>

SOURCE Kaiser Permanente
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Rheumatoid Arthritis Treatment Guidelines Updated
2. Because of Its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy
3. Adoption of Minimally Invasive Prostate Cancer Treatment Options Slow
4. Leading Eating Disorder Treatment Center Identifies Popular Diet Myths
5. California Drug Rehab Program Launches New Life Skills Classes to Young Adults as Substance Abuse Treatment
6. State policies influence drug treatment programs
7. National Headache Foundation Offers Statement, Experts on Appropriate Use of Medications for Migraine Treatment
8. Medical Pot Ineffective as Acute Pain Treatment
9. Younger Patients Seeking More Aesthetic Treatments
10. Prescribed Meds Still Best Treatment for Alcoholism
11. Revolutionary Therapy: Needle-Free Technology for the Treatment Of Blinding Eye Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...variation believed to affect circadian rhythm, ...- New research suggests that an internal body cloc...development of bipolar disorder in children. ,...enetic makeup of 152 children with bipolar disorde... swings, and 140 children without the disorder. Th...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issued ...genomic data. It shows that the lethality of the ...during the virus,s current outbreak in the spring ...f 2.0 (s.d. 0.1). The H1N1 infectivity count, howe... Boston (PRWEB) November 27, 2009 -- Biotech firm ...
(Date:11/27/2009)...ILLY-SUR-SEINE, France, Nov. 27 Te...nal cycling team dedicated to ethical sporting and...ns, announced today that it will become Team Garmi...ical as a new sponsor of the team. Transitions Opt...ve eyewear, offering the most advanced photochromi...
(Date:11/27/2009)...bring unprecedented medical, economic burdens, stu...ay News) -- The number of people with diabetes in ...ext 25 years, a new study predicts. , That woul...ople with the disease, up from 23.7 million today....le with diabetes will triple, the study also warns...
(Date:11/27/2009)... Specialist manufacturers who use medical ...ng millions of dollars by bringing in technology p...sing numbers of pro-active medical manufacturers a...cept stage of their projects, ensuring that progre...esses or potentially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...ol Uniquely Provides Minute-by-Minute and Trend In...ve Diabetes Management, ABBOTT PARK, Ill., March ...roved the FreeStyle Navigator(R) Continuous,Glucos...re glucose levels through a sensor in the back of ...
...ctured majority of convertible notes due June 2008... forward Projects Zevalin(R) net sales revenue...tle-Cell Therapeutics,Inc. (CTI) (Nasdaq: CTIC ; ... completion of Zevalin(R) (Ibritumomab Tiuxetan) a...
...Therapeutics, Inc., leaders in light therapy, prou...A approval, CARLSBAD, Calif., March 12 Photo The...ived FDA approval on its new,over-the-counter ligh... New-U has been clinically proven to reduce perior...
...ent from Georges C. Benjamin, MD, FACP, FACEP (E),...ation, WASHINGTON, March 12 The U.S. Environment...otective National Ambient,Air Quality Standards (N...c Health Association (APHA) is concerned that,the ...
...in poor neighborhoods most likely to watch TVs or ...h 12 (HealthDay News) -- A new survey reports that...t of TVs and computers, and those in poor neighbor...heir neighborhoods," said study author Tracie A. B...
...Sponsor a Recipient of American Academy of Nursing...are Research, SACRAMENTO, Calif., March 12 A stu...-to-patient staffing ratios in California,hospital...itics & Nursing Practice, a peer-reviewed journal ...
Other Medicine News:Health News:FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System 2Health News:FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System 3Health News:FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System 4Health News:FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System 5Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results 2Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results 3Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results 4Health News:Omnilux New-U(TM) Hand-Held Device Receives FDA Approval 2Health News:APHA Says New Ozone Regulations a Missed Opportunity to Protect Public's Health 2Health News:Teens Spending Too Much Screen Time 2Health News:California Study Offers New Perspective on Relationship Between Staffing Ratios and Patient Safety 2Health News:California Study Offers New Perspective on Relationship Between Staffing Ratios and Patient Safety 3Health News:California Study Offers New Perspective on Relationship Between Staffing Ratios and Patient Safety 4
(Date:11/25/2009)... , UNION CITY, Calif., Nov. 25 /PRNewswire-Fir...l products company manufacturing point-of-care blo...verson, chairman and chief executive officer, will...are Conference on Wednesday, December 2, 2009 at 2...w York Palace Hotel in New York City. ,, About...
(Date:11/25/2009)... , CHAPEL HILL, N.C., Nov. 25 /PRNewswire...hat Prabhavathi Fernandes, president and chief exe...21st Annual Health Care Conference at 8:50 a.m. ES...in New York City. Dr. Fernandes will provide an o...inical programs for the treatment of drug-resistan...
(Date:11/25/2009)... , FRAMINGHAM, Mass. and SYDNEY, Nov. 25 /P...nc. (Nasdaq: HTWR ; ASX: HIN), a leading innovato...ulatory support technologies revolutionizing the t...d that it is scheduled to make an investor present... Conference at 8:00 am EST on Wednesday, December ...
Breaking Medicine Technology:HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2PTS Inc Subsidiary Disability Access Corporation Announces 24535 000 in New Contracts and Inspection Orders for July 2009 52196 1PTS Inc Subsidiary Disability Access Corporation Announces 24535 000 in New Contracts and Inspection Orders for July 2009 52196 2BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52194 1BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52194 2BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 52194 3Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4757 1Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4757 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4757 3
...te early non-responders unlikely to subsequently,r...nd may benefit,from earlier change in treatment st...RNewswire-FirstCall/,-- New data presented at the ...rch (ICOSR) suggest that antipsychotic drug,respon...and,challenge the current schizophrenia treatment ...
...ced By an Average of More Than Two Hours Per Day, ...wswire/ --,Adding the once daily, investigational ...M) Extended-Release Tablets to,Parkinson,s patient...y reduced ,off, time, allowing patients to continu...me. ,Off time,describes the return of Parkinson,s...
Other Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 2Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 3Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 5
Back Relief Apron
Surgical Drop-Off Apron
Wrap-Around Back Relief
Vest-Skirt Combination
Medicine Products: